comparemela.com

Latest Breaking News On - Fabien sebille - Page 1 : comparemela.com

Purple Biotech Appoints Dr Yael Margolin to its Board of Directors

Dr. Margolin brings 35 years of expertise in biotechnology, pharma, and venture capital Purple Biotech also announces the resignation of Mr. Fabien Sebille, who served as the Company’s Chief.

Lior fhimaGil efronYael margolinCompany contactTel aviv universityGamida cell ltdCompany board of directorsDrug administrationExchange commissionDenali venturesPurple biotech ltdBristol myers squibbWeitzman institute of scienceRamot at tel aviv universityYale university school of medicineTeva pharmaceuticals

Netris Pharma Raises €7 5M; Extends Series A to €24 4M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Patrick mehlenNetris pharmaChief executive officerFabien sebilleChief business officer

Purple Biotech Issues Letter to Shareholders

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesGil efronRobert gagnonBristol myers squibbSuzana nahum zilberbergExchange commissionDepartment of cancer biologyUniversity of texas md anderson cancer centerCompany contactPurple biotech ltdDrug administrationPurple biotechChief executive officerIsaac israelCancer centerMenashe bar eli

Purple Biotech Issues Letter to Shareholders

REHOVOT, Israel, Feb. 04, 2022 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor

United statesGil efronRobert gagnonBristol myers squibbSuzana nahum zilberbergExchange commissionDepartment of cancer biologyUniversity of texas md anderson cancer centerCompany contactPurple biotech ltdDrug administrationPurple biotechChief executive officerIsaac israelCancer centerMenashe bar eli

Purple Biotech Appoints Senior Business Development

REHOVOT, Israel, Dec. 09, 2021 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage.

City ofUnited kingdomImmunotherapeutics euronextGil efronUniversity of nantesPurple biotech ltdDebiopharm internationalImperial collegeBristol myers squibbBusiness developmentFabien sebilleChief businessExecutive directorAlsace biovalleyTcland expressionTechnology transfer officer

vimarsana © 2020. All Rights Reserved.